Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.

Two clinical studies were undertaken to study the toxicity profile and effects of interleukin-3 (rhIL-3) on chemotherapy-induced myelosuppression. Fifteen patients with recurrent ovarian carcinoma were treated with high dose carboplatin (800 mg m-2). All patients received 5.0 micrograms/kg/d rhIL-3...

Descripción completa

Detalles Bibliográficos
Autores principales: Dercksen, M. W., Hoekman, K., ten Bokkel Huinink, W. W., Rankin, E. M., Dubbelman, R., van Tinteren, H., Wagstaff, J., Pinedo, H. M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968723/
https://www.ncbi.nlm.nih.gov/pubmed/7692922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968723/
https://www.ncbi.nlm.nih.gov/pubmed/7692922

Ejemplares similares